Development and Validation of a Stability-Indicating UPLC Method for the Determination of Hexoprenaline in Injectable Dosage Form Using AQbD Principles

A novel and efficient stability-indicating, reverse phase ultra-performance liquid chromatographic (UPLC®) analytical method was developed and validated for the determination of hexoprenaline in an injectable dosage form. The development of the method was performed using analytical quality by design (AQbD) principles, which are aligned with the future requirements from the regulatory agencies using AQbD principles. The method was developed by assessing the impact of ion pairing, the chromatographic column, pH and gradient elution. The development was achieved with a Waters Acquity HSS T3 (50 × 2.1 mm i.d., 1.8 µm) column at ambient temperature, using sodium dihydrogen phosphate 5 mM + octane-1-sulphonic acid sodium salt 10 mM buffer pH 3.0 (Solution A) and acetonitrile (Solution B) as mobile phases in gradient elution (t = 0 min, 5% B; t = 1 min, 5% B; t = 5 min, 50% B; t = 7 min, 5% B; t = 10 min, 5% B) at a flow rate of 0.5 mL/min and UV detection of 280 nm. The linearity was proven for hexoprenaline over a concentration range of 3.50–6.50 µg/mL (R2 = 0.9998). Forced degradation studies were performed by subjecting the samples to hydrolytic (acid and base), oxidative, and thermal stress conditions. Standard solution stability was also performed. The proposed validated method was successfully used for the quantitative analysis of bulk, stability and injectable dosage form samples of the desired drug product. Using the AQbD principles, it is possible to generate methodologies with enhanced knowledge, which can eventually lead to a reduced regulatory risk, high quality data and lower operational costs.

[1]  F. R. Lourenço,et al.  Development and optimization of a stability-indicating chromatographic method for verapamil hydrochloride and its impurities in tablets using an analytical quality by design (AQbD) approach , 2020 .

[2]  C. Schmied,et al.  Neonatal Outcome After Hexoprenaline Compared with Atosiban After Preterm Premature Rupture of Membranes , 2019, Journal of Fetal Medicine.

[3]  Tim Tome,et al.  Development and Optimization of Liquid Chromatography Analytical Methods by Using AQbD Principles: Overview and Recent Advances , 2019, Organic Process Research & Development.

[4]  M. Zečević,et al.  Comparison of AQbD and grid point search methodology in the development of micellar HPLC method for the analysis of cilazapril and hydrochlorothiazide dosage form stability , 2019, Microchemical Journal.

[5]  Alessandro Morais Saviano,et al.  Design of Experiments (DoE) applied to Pharmaceutical and Analytical Quality by Design (QbD) , 2018, Brazilian Journal of Pharmaceutical Sciences.

[6]  O. Pustotina Effectiveness of dydrogesterone, 17-OH progesterone and micronized progesterone in prevention of preterm birth in women with a short cervix , 2018, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[7]  R. Landau,et al.  Pharmacogenetics in obstetric anesthesia. , 2017, Best practice & research. Clinical anaesthesiology.

[8]  Yimin Hua,et al.  A platform analytical quality by design (AQbD) approach for multiple UHPLC-UV and UHPLC-MS methods development for protein analysis. , 2016, Journal of pharmaceutical and biomedical analysis.

[9]  E. Wynendaele,et al.  An analytical quality by design (aQbD) approach for a L-asparaginase activity method. , 2016, Journal of pharmaceutical and biomedical analysis.

[10]  D. Flockhart,et al.  Is personalized medicine achievable in obstetrics? , 2014, Seminars in perinatology.

[11]  G. L. Reid,et al.  REVERSED-PHASE LIQUID CHROMATOGRAPHIC METHOD DEVELOPMENT IN AN ANALYTICAL QUALITY BY DESIGN FRAMEWORK , 2013 .

[12]  G. Hofmeyr,et al.  Acute tocolysis for uterine tachysystole or suspected fetal distress. , 2012, Cochrane Database of Systematic Reviews.

[13]  Jessica A Cantu,et al.  Tocolytic therapy for acute preterm labor. , 2012, Obstetrics and gynecology clinics of North America.

[14]  T. Raglione,et al.  Regeneration of tetrabutylammonium ion-pairing reagent distribution in a gradient elution of reversed phase ion-pair chromatography. , 2011, Journal of Chromatographic Science.

[15]  J. Ståhlberg Ion-Pair Chromatography and Related Techniques , 2010 .

[16]  R. M. El-Nashar Flow Injection Potentiometric Assay of Hexoprenaline in Its Pure State, Pharmaceutical Preparations, and Biological Samples , 2008, Journal of automated methods & management in chemistry.

[17]  K. Kuśmierek,et al.  Simultaneous determination of tiopronin and d-penicillamine in human urine by liquid chromatography with ultraviolet detection. , 2007, Analytica chimica acta.

[18]  B. Lu,et al.  Reversed phase ion-pair high performance liquid chromatographic gradient separation of related impurities in 2,4-disulfonic acid benzaldehyde di-sodium salt. , 2006, Journal of chromatography. A.

[19]  H. Stuppner,et al.  Simultaneous determination of Ephedra sinica and Citrus aurantium var. amara alkaloids by ion-pair chromatography. , 2005, Talanta.

[20]  W. Schöll,et al.  A prospective randomised trial of atosiban versus hexoprenaline for acute tocolysis and intrauterine resuscitation , 2004, BJOG : an international journal of obstetrics and gynaecology.

[21]  S. Deming,et al.  Retention mechamism for reversed-phase ion-pair liquid chromatography , 1979 .

[22]  R. N. Brogden,et al.  Hexoprenaline: A Review of its Pharmacological Properties and Therapeutic Efficacy with Particular Reference to Asthma , 1977, Drugs.

[23]  Essentials in Modern HPLC Separations , 2022 .

[24]  B. Jahnavi,et al.  QbD Considerations for Analytical Development , 2019, Pharmaceutical Quality by Design.

[25]  M. Berkovitch,et al.  Antiasthmatic and cough medication , 2015 .

[26]  Or Q8, Q9, & Q10 Questions and Answers -- Appendix: Q&As from Training Sessions (Q8, Q9, & Q10 Points to Consider) , 2012 .

[27]  J. Neilson,et al.  Betamimetics for inhibiting preterm labour. , 2004, The Cochrane database of systematic reviews.